Paper39775320
The prognosis and immune repertoire characteristics of HBsAg and anti-HBs double positive chronic hepatitis B patients.
Liang H and 11 others. Clin Exp Med, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. The prognosis and immune repertoire characteristics of HBsAg and anti-HBs double positive chronic hepatitis B patients. Papers, record 39775320. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39775320
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The prognosis and immune repertoire characteristics of HBsAg and anti-HBs double positive chronic hepatitis B patients.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hepatitis B, Chronic | Major topic |
| Hepatitis B Surface Antigens | Major topic |
| Hepatitis B Antibodies | Major topic |
| Humans | |
| Male | |
| Female | |
| Middle Aged | |
| Adult | |
| Prognosis | |
| Retrospective Studies | |
| China | |
| Immunoglobulin Heavy Chains | |
| Young Adult | |
| Aged | |
| Receptors, Antigen, B-Cell |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| No. 2320001006088 | Foshan science and technology plan project | PubMed | ||
| No. 202102020024 | Guangzhou science and technology plan project | PubMed | ||
| No. 2022J007 | Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical University | PubMed | ||
| No. 81871712 | National Natural Science Foundation of China | PubMed |
Source PubMed
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37024566 | Global burden of hepatitis B virus: current status, missed opportunities and a call for action. | Nat Rev Gastroenterol Hepatol | 2023 | https://conductscience.org/library/papers/37024566 | PubMed |
| 2 | 37719965 | Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022). | J Clin Transl Hepatol | 2023 | https://conductscience.org/library/papers/37719965 | PubMed |
| 3 | 16447285 | Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. | Hepatology | 2006 | https://conductscience.org/library/papers/16447285 | PubMed |
| 4 | 17628874 | Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase. | Hepatology | 2007 | https://conductscience.org/library/papers/17628874 | PubMed |
| 5 | 33867835 | Paradoxical HBsAg and anti-HBs coexistence among Chronic HBV Infections: Causes and Consequences. | Int J Biol Sci | 2021 | https://conductscience.org/library/papers/33867835 | PubMed |
| 6 | 26010146 | Sequence analysis of the HBV S protein in Chinese patients with coexisting HBsAg and anti-HBs antibodies. | J Med Virol | 2015 | https://conductscience.org/library/papers/26010146 | PubMed |
| 7 | 21840251 | Mutations in hepatitis B virus DNA from patients with coexisting HBsAg and anti-HBs. | J Clin Virol | 2011 | https://conductscience.org/library/papers/21840251 | PubMed |
| 8 | 24127328 | Coexistence of hepatitis B surface antigen and antibody to hepatitis B surface may increase the risk of hepatocellular carcinoma in chronic hepatitis B virus infection: a retrospective cohort study. | J Med Virol | 2014 | https://conductscience.org/library/papers/24127328 | PubMed |
| 9 | 11696228 | Characterization of a novel hepatitis B virus mutant: demonstration of mutation-induced hepatitis B virus surface antigen group specific "a" determinant conformation change and its application in diagnostic assays. | Transfus Med | 2001 | https://conductscience.org/library/papers/11696228 | PubMed |
| 10 | 19623669 | Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection. | J Med Virol | 2009 | https://conductscience.org/library/papers/19623669 | PubMed |
| 11 | 16501106 | Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of "a" determinant variants. | J Virol | 2006 | https://conductscience.org/library/papers/16501106 | PubMed |
| 12 | 10535488 | Detection of pre-S/S gene mutants in chronic hepatitis B carriers with concurrent hepatitis B surface antibody and hepatitis B surface antigen. | J Gastroenterol | 1999 | https://conductscience.org/library/papers/10535488 | PubMed |
| 13 | 25542467 | Coexistence of circulating HBsAg and anti-HBs antibodies in chronic hepatitis B carriers is not a simple analytical artifact and does not influence HBsAg quantification. | J Clin Virol | 2015 | https://conductscience.org/library/papers/25542467 | PubMed |
| 14 | 28198078 | Mutation in the S gene of hepatitis B virus and anti-HBs subtype-nonspecificity contributed to the co-existence of HBsAg and anti-HBs in patients with chronic hepatitis B virus infection. | J Med Virol | 2017 | https://conductscience.org/library/papers/28198078 | PubMed |
| 15 | 26963138 | Current status and recent advances of next generation sequencing techniques in immunological repertoire. | Genes Immun | 2016 | https://conductscience.org/library/papers/26963138 | PubMed |
| 16 | 34522220 | The methods and advances of adaptive immune receptors repertoire sequencing. | Theranostics | 2021 | https://conductscience.org/library/papers/34522220 | PubMed |
| 17 | 34722192 | Guidelines for Prevention and Treatment of Chronic Hepatitis B. | J Clin Transl Hepatol | 2021 | https://conductscience.org/library/papers/34722192 | PubMed |
| 18 | 17573090 | Clinical and virological significance of the co-existence of HBsAg and anti-HBs antibodies in hepatitis B chronic carriers. | Virology | 2007 | https://conductscience.org/library/papers/17573090 | PubMed |
| 19 | 25953851 | The MEME Suite. | Nucleic Acids Res | 2015 | https://conductscience.org/library/papers/25953851 | PubMed |
| 20 | 26663578 | Epidemiological characteristics of the carriers with coexistence of HBsAg and anti-HBs based on a community cohort study. | J Viral Hepat | 2016 | https://conductscience.org/library/papers/26663578 | PubMed |
Genes15
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39775320
GET https://conductscience.org/api/papers/v1/39775320/references?page=2